loading
전일 마감가:
$3.07
열려 있는:
$3.45
하루 거래량:
17.58M
Relative Volume:
17.44
시가총액:
$1.68M
수익:
$29.78M
순이익/손실:
$-39.94M
주가수익비율:
-0.0539
EPS:
-61.9139
순현금흐름:
$-16.12M
1주 성능:
-5.87%
1개월 성능:
-58.55%
6개월 성능:
-27.21%
1년 성능:
-96.74%
1일 변동 폭
Value
$3.25
$3.93
1주일 범위
Value
$2.86
$3.93
52주 변동 폭
Value
$0.432
$103.95

22nd Century Group, Inc. Stock (XXII) Company Profile

Name
명칭
22nd Century Group, Inc.
Name
전화
716-270-1523
Name
주소
8560 Main Street, Williamsville, NY
Name
직원
79
Name
트위터
@_xxiicentury
Name
다음 수익 날짜
2024-12-12
Name
최신 SEC 제출 서류
Name
XXII's Discussions on Twitter

XXII을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
XXII
22nd Century Group, Inc.
3.35 1.06M 29.78M -39.94M -16.12M -61.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
464.20 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.00 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.53 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
596.63 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.67 31.54B 3.81B -644.79M -669.77M -6.24

22nd Century Group, Inc. Stock (XXII) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-07-21 개시 Alliance Global Partners Buy
2022-06-15 개시 Craig Hallum Buy
2022-03-08 개시 ROTH Capital Buy
2021-07-23 개시 Cowen Outperform
2017-10-16 재확인 Chardan Capital Markets Buy
2016-08-11 재확인 Chardan Capital Markets Buy
모두보기

22nd Century Group, Inc. 주식(XXII)의 최신 뉴스

pulisher
02:06 AM

XXII Stock Surge: Time for Action? - StocksToTrade

02:06 AM
pulisher
10:04 AM

22nd Century Group: Resurgence and Future Prospects - StocksToTrade

10:04 AM
pulisher
Jul 27, 2025

What catalysts could drive 22nd Century Group Inc. stock higher in 2025Get exclusive market insights for better trading - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is 22nd Century Group Inc. a growth stock or a value stockFree Trading Strategy Suggestions - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

22nd Century Group Inc. Stock Performance After Earnings: Historical InsightsFree AI-Powered Stock Predictions - beatles.ru

Jul 27, 2025
pulisher
Jul 26, 2025

Why 22nd Century Group Inc. stock attracts strong analyst attentionFree Stock Market Insider Analysis - metal.it

Jul 26, 2025
pulisher
Jul 26, 2025

How 22nd Century Group Inc. stock performs during market volatilityTrade Ready Signal - Metal.it

Jul 26, 2025
pulisher
Jul 25, 2025

Should I buy 22nd Century Group Inc. stock before earningsUnprecedented profits - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

VLN Commercial Launches Confirm Viability of the FDA's Proposed Reduced Nicotine Mandate - ADVFN Brasil

Jul 25, 2025
pulisher
Jul 25, 2025

What drives 22nd Century Group Inc. stock priceSkyrocketing investment returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Is 22nd Century Group Inc. a good long term investmentAccelerated financial growth - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about 22nd Century Group Inc. stockExplosive wealth accumulation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

22nd Century Group Inc. Stock Analysis and ForecastTremendous financial leverage - Autocar Professional

Jul 23, 2025
pulisher
Jul 18, 2025

22nd Century Group Expands VLN Cigarette Sales Across U.S. - Tobacco Reporter

Jul 18, 2025
pulisher
Jul 18, 2025

Why Did 22nd Century Group Drop 10.18% Despite FDA Approval? - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

22nd Century Group hopes new reduced nicotine cigarette resonates with smokers - Greensboro News and Record

Jul 18, 2025
pulisher
Jul 17, 2025

22nd Century Surges to 480th in Trading Volume with 1932% Spike Amid Major Acquisition - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

XXII Secures Broader State Approvals for Product Sales Expansion - GuruFocus

Jul 17, 2025
pulisher
Jul 17, 2025

22nd Century Reports Expanded State Authorization Progress to Se - GuruFocus

Jul 17, 2025
pulisher
Jul 17, 2025

22nd Century Reports Expanded State Authorization Progress to Sell VLN®, Partner VLN® and Conventional Products - The Globe and Mail

Jul 17, 2025
pulisher
Jul 17, 2025

22nd Century Group’s Nicotine-Reduction Progress Accelerates Market Growth - StocksToTrade

Jul 17, 2025
pulisher
Jul 17, 2025

22nd Century Group shares surge 56.11% intraday after expanding VLN® low-nicotine cigarette partnerships and meeting FDA's proposed nicotine limit. - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

22nd Century Group Stock Soars as FDA’s Nicotine Crackdown Sparks Opportunity - RagingBull

Jul 17, 2025
pulisher
Jul 17, 2025

22nd Century Stocks: Growth or Bubble? - timothysykes.com

Jul 17, 2025
pulisher
Jul 17, 2025

Why Is 22nd Century Stock (XXII) Up 85% Today? - TipRanks

Jul 17, 2025
pulisher
Jul 17, 2025

22nd Century Group (XXII) Stock Soars 110.04% on FDA Compliance - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

22nd Century Group Stock Jumps 75% After Hour On News Of Reduced-Nicotine Push - Benzinga

Jul 17, 2025
pulisher
Jul 16, 2025

22nd Century Group stock soars after expanding VLN cigarette partnerships - Investing.com

Jul 16, 2025

22nd Century Group, Inc. (XXII) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.21
price down icon 0.79%
$37.16
price up icon 1.35%
$103.25
price down icon 0.60%
$27.52
price down icon 3.96%
$113.06
price down icon 1.96%
biotechnology ONC
$297.26
price up icon 1.99%
자본화:     |  볼륨(24시간):